# David Gerber, M.D. – FDA Inspection, Aug 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/david-gerber-md/dceb0890-3088-489c-bca7-a1f150c015ac
Source feed: FDA_Inspections

> FDA inspection 1099852 of David Gerber, M.D., August 19, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099852
- Company Name: David Gerber, M.D.
- Inspection Date: 2019-08-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Company Rep](https://www.keypedia.com/people/camille-d-brown/419869d2-1810-40ea-8e8a-687de7013f6a)

Company: https://www.keypedia.com/companies/david-gerber-md/1d94b600-3b17-419d-90c1-f4291ff6526f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
